MetaCap

Tarsus Pharmaceuticals Statistics

NASDAQ: TARSHealth CareBiotechnology: Biological Products (No Diagnostic Substances)USD

73.01-4.66 (-6.00%)

At close: Nov 20, 4:00 PM ET · Delayed 15 min

Tarsus Pharmaceuticals by the numbers

Tarsus Pharmaceuticals has a market capitalization of $3.60 billion based on 49.31M shares outstanding. With trailing EPS of $-15.86, Tarsus Pharmaceuticals is unprofitable on a 12-month basis, so earnings-based valuation ratios do not apply. The stock trades 1.5% below its 50-day average and 6.9% above its 200-day average.

Average daily trading volume is 871.07K shares, or about $63.6 million in dollar volume.

Summary generated from market data by MetaCap's automated system. Methodology

TARS valuation vs. peer median

TARS compared with the median of 8 peer companies
MetricTARSPeer medianDifference
Market cap$3.60B$3.07B+17%
Avg. volume871.07K2.12M-59%

Peer median across 8 companies: RLAY, CRSP, IOVA, DNLI, VCEL, ADMA, ADPT, BEAM.

Valuation

Price / sales (latest FY)
7.98
EPS (TTM)
$-15.86

Price and trading

Previous close
77.67
Open
77.09
Day range
72.74 – 78.11
52-week range
53.89 – 91.53
52-week change
-8.35%
Beta
—
Volume
706.77K

Dividends and events

Annual dividend
None

Additional statistics

Market Cap
3.60B
Forward Pe
339.58
Eps
-15.86
Dividend Yield
0.00%
Dividend Rate
0.00
Week52 High
91.53
Week52 Low
53.89
Avg Volume
871.07K
Shares Outstanding
49.31M
Ma50
74.09
Ma200
68.27
Earnings Date
Nov 3, 2026
Pct From52w High
-20.23%
Pct From52w Low
35.48%

Related